_1777370220974_847775619.png&w=48&q=75){kind=small}
Blood test identifies most aggressive prostate cancers
A new blood test called Stockholm3 shows promise in detecting aggressive prostate cancer more effectively than the traditional PSA test. In a study involving over 12,000 men, Stockholm3 identified 90% of severe cases compared to 74% by PSA, with fewer missed serious cancers and similar rates of false positives. Researchers suggest that this more precise test could enable earlier detection and reduce unnecessary follow-up procedures, although it is not yet available for sale in the U.S.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)